Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001401225-14-000004

Options or other derivatives

  • CFO bought 500,000 shares at $0.11 ($55,000)

From the SEC's structured data for this filing

Trades in this filing

Bhullar Baljinder · CFO

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2014-12-23 Purchase : show line 1 in the form Stock Options +500,000 $0.11 $55,000 $0.11 2019-12-23 500,000 1,075,000 D
Loading xslF345X03/primary_doc.xml…